MT-II stimulates melanogenesis via MC1R on melanocytes darker pigmentation following short subcutaneous dosing. In the CNS, MT-II can trigger erections without sexual stimulation, pointing to central melanocortin circuitry (hypothalamic and spinal sites). Discovery & Research Milestones Discovery & Research Milestones Originated at the University of Arizona in the 1980s, where researchers were exploring sunless tanning agents. Built as a short, stable analog of -MSH, improving its half-life and activity compared to the natural hormone. Early studies tested Melanotan II in skin pigmentation disorders and sexual dysfunction, but it never achieved regulatory approval
Fruit and vegetable intake and survival from non-Hodgkin lymphoma: does an apple a day keep the doctor away
In the context of liraglutide treatment, Nur77 regulation may help reduce endothelial cell dysfunction in type 2 diabetes and metabolic syndrome [62]
My friends comment nudged me to truly examine what was happening to my body
A score above 2.9 indicates significant insulin resistance
8 This study, which took place over a five-year period, surely contributed to the FDAs approval of semaglutide in early 2024 for use in this population, and demonstrated that, in addition to managing diabetes and obesity, GLP1 receptor agonists offer value in reducing cardiovascular event risk